Abstract:Objective To campare the diagnostic value of contrast-enhanced ultrasound(CEUS) and International Ovarian Tumor Analysis (IOTA) simple rules in the differential diagnosis of adnexal tumors . Methods For the 101 suspicious malignant adnexal tumors discovered by conventional ultrasound ,IOTA simple rules and CEUS were performed before operation . Tumors were divided into benign ,uncertain and malignant according to IOTA simple rules . Tumors were scored by CEUS according to the membrane integrity ,coating thickness uniformity ,separation enhancement ,enhance strength ( no enhancement ,low enhancement ,equal or high enhancement) ,and enhanced performance( uniform and non-uniform) . The ROC curve was drawn with the pathological results as the gold standard ,and the best boundary value was obtained . Finally ,the diagnostic efficiency of the diagnostic methods were analyzed . Results ①According to the ROC curve analysis ,the area under the curve of IOTA simple rules was 0 .757( P ＝0 .000) . When the uncertainty type was classified as benign ,the random index was 0 .41 ,the sensitivity was 61 .54% ,and the specificity was 79 .59% . When the uncertainty type was classified as malignant ,the random index was 0 .31 ,the sensitivity was 96 .15% ,and the specificity was 34 .69% . When the uncertain types were excluded the Youden index was 0 .77 ,the sensitivity was 76 .19% ,and the specificity was 89 .47% . ②The differences in the membrane integrity , coating thickness uniformity , separation enhancement , enhance strength , enhanced performance between benign and malignant tumors were statistically significant( P ＜ 0 .01) . ③According to the ROC curve analysis ,the area under the curve of CEUS was 0 .914( P ＝ 0 .000) ,cut-off value was 3 score . The Youden index ,sensitivity and specificity of evaluating benign and malignant adnexal tumors were 0 .80 ,78 .85% and 91 .84% respectively . ④ The tumors evaluated as benign by IOTA simple rules was classified as benign . The tumors evaluated as malignant by IOTA simple rules were classified as malignant . The tumors evaluated as uncertain by IOTA simple rules and scored less than or equal to 3 points according to CEUS were classified as benign . The tumors evaluated as uncertain by IOTA simple rules and scored more than 3 points according to CEUS were classified as malignant . According to the ROC curve analysis ,the area under the curve of CEUS combined with IOTA simple rules was 0 .831 ( P ＝0 .000) . The Youden index ,sensitivity and specificity in evaluating benign and malignant adnexal tumors were respectively 0 .66 ,86 .54% and 79 .59% respectively . Conclusions CEUS has a higher diagnostic efficiency than IOTA Simple Rules and the two combined in the diagnosis of adnexal tumors .

Comparison of Contrast-Enhanced Ultrasound, IOTA Simple Rules and O-RADS for Assessing the Malignant Risk of Sonographically Appearing Solid Ovarian Masses.

Differentiating Benign From Malignant Ovarian Masses With Solid Components: Diagnostic Performance of CEUS Combined With IOTA Simple Rules and O-RADS

Value of Scoring by Contrast-Enhanced Ultrasound Combined with Ultrasonic Elastography in Differential Diagnosis of BI-RADS 4 Lesions

Contrast-enhanced ultrasound for differential diagnosis of benign and malignant ovarian tumors: systematic review and meta-analysis.

Contrast-enhanced ultrasound combined with Ovarian-Adnexal Reporting and Data System US risk stratification and management system for diagnosis of adnexal masses

Comparison of the Value of Contrast Enhanced Ultrasound and International Ovarian Tumor Analysis ( IOTA) Simple Rules in the Differential Diagnosis of Adnexal Tumors

Diagnostic Accuracy of Ultrasound Classifications – O-RADS US V2022, O-RADS US V2020, and IOTA SR – in Distinguishing Benign and Malignant Adnexal Masses: Enhanced by Combining O-RADS US V2022 with Tumor Marker HE4

Integrating Contrast-enhanced US to O-RADS US for Classification of Adnexal Lesions with Solid Components: Time-intensity Curve Analysis versus Visual Assessment

Efficacy of IOTA simple rules, O-RADS, and CA125 to distinguish benign and malignant adnexal masses

Adnexal masses: Diagnostic performance of contrast‐enhanced ultrasound using the simple rules from the International Ovarian Tumor Analysis group

[Diagnostic Value of Contrast-Enhanced Ultrasonography in Ovarian Tumors].

Analysis of the contrast-enhanced ultrasound in diagnosis of 47 cases ovarian tumors

Diagnostic Efficiency of Gynecologic Imaging Reporting and Data System Combined With 3-dimensional Contrast-enhanced Ultrasound Scoring System in Evaluating Ovarian Tumor

Conventional, Doppler and Contrast-Enhanced Ultrasonography in Differential Diagnosis of Ovarian Masses

Significance of the Contrast-enhanced Ultrasound in Diagnosis of Ovarian Tumors

A Modified CEUS Risk Stratification Model for Adnexal Masses with Solid Components: Prospective Multicenter Study and Risk Adjustment

Added Value of Contrast-Enhanced Ultrasound to Conventional Ultrasound for Characterization of Indeterminate Soft-Tissue Tumors.

Validation of American College of Radiology Ovarian-Adnexal Reporting and Data System Ultrasound (O-RADS US): Analysis on 1054 Adnexal Masses

Comparative Study of the Efficacy of the Ovarian-Adnexa Reporting and Data System Ultrasound Combined with Contrast-Enhanced Ultrasound and the ADNEX MR Scoring System in the Diagnosis of Adnexal Masses.

Contrast-enhanced Ultrasound for Differentiating Benign from Malignant Solid Small Renal Masses: Comparison with Contrast-Enhanced CT

Contrast-Enhanced UltraSound (CEUS)-based characterization solid renal masses: a role for quantitative imaging approaches